Showing posts with label Downstream Processing Market. Show all posts
Showing posts with label Downstream Processing Market. Show all posts

APAC Region will have the Fastest Growth in the Downstream Processing Market

The total revenue of was downstream processing market was above $21 billion in 2021, which will advance at a growth rate of above 10% in the years to come to reach $51 billion by 2030. This is ascribed to factors such as the biotechnology sector expanding globally, the speedy increase in R&D investment in the biopharmaceutical industry, and contract manufacturing administrations gaining importance. Also, there have been implausible occasions in biotechnology manufacturing, which have faster the expansion of the industry globally.


Antibodies production will have the fastest growth, advancing at a growth rate of approximately 11%, in the future. Due to the increased need for mAb, the need for antibody manufacturing is increasing at the highest rate. The introduction of new products for the effective purifying of antibodies also pushes the development of the industry. For example, in the month of January 2021, Cytiva introduced the HiScreen Fibro Prisma for the purification and procedure development of mAb.

Because of the fast surge in R&D efforts pertinent to cutting-edge bioprocess technologies, high-data process development, perfusion chromatography systems, and incessant downstream processing systems for multicomponent separations, the high-resolution membrane systems are extensively adopted. This has led to the increase in the requirement for improved and advanced bioprocessing know-how for addressing the cleansing of a bottleneck.

Conversely, North America had the largest revenue share, of above 32%, in the year 2021. This is attributable to the quick rise in government investment for, high medical costs, bioprocess technologies, developed healthcare infra, and the existence of market stalwarts. Also, this region has seen many companies involved in collaboration actions with healthcare behemoths that are profoundly funding the biopharma industry and vaccine research and development.

With the increasing commercial success of biopharmaceuticals and increasing adoption of innovative technology and biotech processes, the demand for downstream processing procedures is on the rise all over the world.

Browse detailed report on Downstream Processing Market Demand Forecast Report, 2030


Share:

Popular Posts